Back

mHealth-based management of heart failure during the early post-discharge period across frailty profiles: a post-hoc sub-analysis of the HERMeS multicentre randomised controlled trial

11 May 2026 (09:30 - 10:15)
Organised by: Logo
Congress Presentation Part of: Health and patient-facing digital care Remote Patient Monitoring and Telehealth Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Sergi Yun Viladomat

Bellvitge University Hospital, Hospitalet De Llobregat (Spain)

5 More presentations in this session

Presentation thumbnail
Expert agreement on the content of the RAPHAEL palliative care approach and monitoring instrument for heart failure: an international delphi study
Miss J. De Leeuw (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Integrating mhealth-based solutions in heart failure management during the vulnerable phase in the oldest-old patients: a sub-analysis of the HERMeS multicentre randomised controlled trial
Doctor S. Jovells-Vaque (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Initial data from the HFOS1 study : High adherence to telemonitoring in congestive heart failure patients is associated with lower all-cause mortality and hospitalization
Doctor T. Garban (Carquefou, FR)
Abstract Slides
Presentation thumbnail
Contemporary post-discharge management in heart failure at home (STRONG@HOME)
Mr J. Rolland (Oslo, NO)
Abstract Slides
Presentation thumbnail
AZIMUTH trial: a smartphone, app-based, E-health-integrated model of care for heart failure patients
Associate Professor D. D'Amario (Novara, IT)
Abstract Slides

Access the full session

Session thumbnail
Health and patient-facing digital care

The Event

Event poster

Heart Failure 2026

11 May 2026 09:30 CET
You may be interested in
thumbnail
Congress Session
How to implement a successful telemedicine program in heart failure
thumbnail
Congress Session
Evolutions in arrythmia and syncope management
thumbnail
Congress Presentation
Newcard telemonitoring system improves survival at a lower cost than traditional approaches in chronic heart failure patients as assessed by data extract from the French National Health Data System

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources